# Feature Flag Architecture & Controlled Phased Rollout Plan

## 1. Zero-Unconstrained-Global-Rollout Invariant

Clinical healthcare platforms cannot tolerate "big-bang" 100% global feature releases. A regression in appointment booking, clinical FHIR parsing, or emergency card availability can compromise patient safety.

All Healthogram 2.1 features are governed by `FeatureFlagService` with phased rollouts.

---

## 2. Standard Feature Flag Catalog

| Feature Flag Key | Default | Rollout Target | Constraints / Gates |
| :--- | :--- | :--- | :--- |
| `health_passport_v2_enabled` | `true` | 100% (GA) | Enforces provenance and AES-GCM data isolation |
| `health_connect_enabled` | `true` | 50% | Android 14+ devices only |
| `fhir_export_enabled` | `true` | 100% (GA) | Authenticated biometric gate required before bundle export |
| `fhir_import_enabled` | `true` | 30% (Alpha) | Whitelisted clinicians and patient testers |
| `paper_prescription_ocr_enabled`| `true` | 40% (Pilot) | Requires mandatory side-by-side human review gate |
| `creator_monetization_enabled` | `true` | 100% (GA) | Minor-unit integer financial ledger |
| `seller_monetization_enabled` | `true` | 100% (GA) | Integrated with marketplace orders |
| `organization_monetization_enabled`| `true` | 25% (Alpha) | Verified clinics and hospital accounts |
| `emergency_card_enabled` | `true` | 100% (GA) | Strict opt-in, non-comprehensive payload only |
| `appointment_system_v2_enabled` | `true` | 100% (GA) | Privacy-safe notifications enabled |
| `healthcare_ai_assistance_enabled`| `true` | 50% (Pilot) | Airgapped from generic social AI |
| `multilingual_arabic_enabled` | `true` | 100% (GA) | Native RTL layout support |
| `international_marketplace_enabled`| `true` | 100% (GA) | Country-configured currencies and tax |

---

## 3. Five-Phase Release Methodology

1. **Phase 1: Internal QA & Staging**: Full automated test suite passing (`HealthPassport21TestSuite`), security pen-testing, and compliance checks.
2. **Phase 2: Closed Alpha**: Whitelisted verified medical professionals and partner clinics in Muscat and Riyadh.
3. **Phase 3: Controlled Pilot Country**: 50% rollout in Oman (`OM`) with direct monitoring of error rates and user feedback.
4. **Phase 4: Expanded Regional Rollout**: Expansion to Saudi Arabia (`SA`) and UAE (`AE`) with ZATCA and DHA regulatory compliance verified.
5. **Phase 5: Global General Availability (GA)**: 100% rollout across all supported territories with real-time kill-switch monitoring.
